All In MedTech

Device Trial Radar · NCT04233203

Faster Aspart on Insulin-pump Treated T1DM Patients

Effectiveness and Safety of Insulin Faster Aspart on Continuous Subcutaneous Insulin Infusion Treated Adult Type 1 Diabetes Mellitus Patients in Routine Clinical Practice

Last checked: Nov 19, 2026Latest source record: Feb 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

48

Actual

Start

Jan 31, 2020

Primary completion

Dec 31, 2020

Study completion Dec 31, 2020

Sponsor

Lead sponsor
Jesús Moreno FernándezAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Castilla-La Mancha
First posted
Jan 18, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Observational retrospective study about effectiveness and safety of insulin Faster Aspart on continuous subcutaneous insulin infusion treated adult Type 1 Diabetes Mellitus (T1DM) patients in routine clinical practice.

Conditions

  • Type 1 Diabetes

Interventions

  • Insulin Faster AspartDrug

    Currently receiving Faster Aspart during 3 or more months.

  • Insulin pumpDevice

    Currently receiving CSII therapy during 6 or more months.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MAGETime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Obispo Rafael Torija, St.

    Ciudad Real, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.